Menu

Markets

Research

News

Learn

AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

TCR2 Therapeutics Inc. TCRR

Full chart Compare
Set alert

Price alert · TCRR

All alert types
1.48 0.00 (+0.00%)

At closeMay 31, 2023, 4:00 PM EDT

1.48 Day range 1.48

52-week range unavailable

Financial health

Altman Z-Score

-7.16 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.3×
FY 2016: -7.8×FY 2017: -5.9×FY 2018: -14.4×FY 2019: -6.3×FY 2020: -12.9×FY 2021: -1.8×FY 2022: -0.3×
FY 2016 5y median -6.3× FY 2022
P/S 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×
FY 2016 5y median 0.0× FY 2022
P/B 0.3×
FY 2016: -6.5×FY 2017: -2.9×FY 2018: -4.1×FY 2019: 1.9×FY 2020: 3.7×FY 2021: 0.6×FY 2022: 0.3×
FY 2016 5y median 0.6× FY 2022
P/FCF -0.3×
FY 2016: -7.5×FY 2017: -6.2×FY 2018: -17.7×FY 2019: -6.7×FY 2020: -13.5×FY 2021: -1.9×FY 2022: -0.3×
FY 2016 5y median -6.7× FY 2022
EV/EBITDA -0.7×
FY 2016: -7.2×FY 2017: -4.5×FY 2018: -12.7×FY 2019: -4.7×FY 2020: -11.5×FY 2021: 0.2×FY 2022: -0.7×
FY 2016 5y median -4.7× FY 2022
EV/Sales 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×
FY 2016 5y median 0.0× FY 2022
FCF Yield -303.0%
FY 2016: -13.3%FY 2017: -16.1%FY 2018: -5.7%FY 2019: -15.0%FY 2020: -7.4%FY 2021: -52.6%FY 2022: -303.0%
FY 2016 5y median -15.0% FY 2022

Profitability

Gross Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2016 5y median 0.0% FY 2022
Operating Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2016 5y median 0.0% FY 2022
Net Margin 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2016 5y median 0.0% FY 2022
ROE -107.8%
FY 2016: 83.4%FY 2017: 49.7%FY 2018: 28.3%FY 2019: -29.7%FY 2020: -28.4%FY 2021: -35.5%FY 2022: -107.8%
FY 2016 5y median -29.7% FY 2022
ROIC -78.9%
FY 2016: -57.4%FY 2017: -63.3%FY 2018: -21.3%FY 2019: -31.9%FY 2020: -28.9%FY 2021: -32.4%FY 2022: -78.9%
FY 2016 5y median -31.9% FY 2022
ROA -72.9%
FY 2016: -54.3%FY 2017: -59.3%FY 2018: -18.7%FY 2019: -28.2%FY 2020: -27.3%FY 2021: -30.9%FY 2022: -72.9%
FY 2016 5y median -28.2% FY 2022

Growth (YoY)

Revenue 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2016 FY 2022
Operating Income -53.9%
FY 2016: 0.0%FY 2017: -32.7%FY 2018: -100.7%FY 2019: -94.2%FY 2020: -33.7%FY 2021: -45.2%FY 2022: -53.9%
FY 2016 FY 2022
EPS (diluted) -49.4%
FY 2016: 0.0%FY 2017: -32.1%FY 2018: 58.8%FY 2019: -115.2%FY 2020: -6.2%FY 2021: -9.6%FY 2022: -49.4%
FY 2016 FY 2022
Free Cash Flow -25.6%
FY 2016: 0.0%FY 2017: -21.2%FY 2018: -59.3%FY 2019: -128.5%FY 2020: -41.3%FY 2021: -45.6%FY 2022: -25.6%
FY 2016 FY 2022

Financial Health

Current Ratio 2.8×
FY 2016: 17.9×FY 2017: 16.8×FY 2018: 23.0×FY 2019: 21.7×FY 2020: 26.6×FY 2021: 14.8×FY 2022: 2.8×
FY 2016 5y median 21.7× FY 2022
Quick Ratio 2.8×
FY 2016: 17.9×FY 2017: 16.8×FY 2018: 23.0×FY 2019: 21.7×FY 2020: 26.6×FY 2021: 14.8×FY 2022: 2.8×
FY 2016 5y median 21.7× FY 2022
Debt / Equity 0.4×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.1×FY 2022: 0.4×
FY 2016 5y median 0.0× FY 2022
Net Debt / EBITDA -0.2×
FY 2016: 0.8×FY 2017: 1.6×FY 2018: 2.0×FY 2019: 1.3×FY 2020: 1.4×FY 2021: 2.0×FY 2022: -0.2×
FY 2016 5y median 1.4× FY 2022
Interest Coverage -2.6×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: -2.6×
FY 2016 5y median 0.0× FY 2022

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2016 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%
FY 2016 5y median 0.0% FY 2022

Annual · latest fiscal year ends 2022-12-31